BRIEF-Serendex Pharmaceuticals keeps objectives and timeliness unchanged

Fri Aug 1, 2014 5:09am EDT

Related Topics

Aug 1 (Reuters) - Serendex Pharmaceuticals A/S : * Maintains objectives and timelines unchanged * Says still expects to present the first results of pre clinical program in

late September 2014 * Says expects to start sales of GM-CSF (Molgradex) in a name patient program

end of October 2014 * Source text for Eikon * Further company coverage

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.